On Tuesday, Loyal for Dogs announced that its first-of-its-kind longevity drug received the first of three green lights needed for FDA approval. The decision, made in early November, is essentially a vote of confidence from federal regulators that this drug should actually work to extend dogs' lifespans, based on evidence so far.